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ABSTRACT 
This study was designed to identify the financial burdens associated with purchasing 
medical foods and the impact this has on the dietary management of adults with PKU. 
PKU is a genetic disorder in which the body cannot metabolize the amino acid, 
phenylalanine, which occurs in all foods with protein. Dietary treatment of foods low in 
protein along with medical supplementation is required for the treatment of PKU. If PKU 
is left untreated this can lead to severe neurological damage. Medical guidelines indicate 
that dietary treatment is needed for the duration of one's life, but the medical foods 
needed are expensive and individuals receive minimal to no insurance coverage. An 
online questionnaire survey was designed to identify different financial barriers 
associated with the cost, PKU treatment modalities and how identified barriers affect the 
management of the medical nutrition therapy in adults with PKU. Sixteen participants 
were included in this study and descriptive statistics were used to analyze the collected 
data. The results showed that participants paid out-of-pocket for alternative medical 
protein products and modified low-protein foods the most, ranging from $100-$500. The 
results also showed that participants perceived the cost of medical foods to be expensive, 
and felt that insurance coverage was inadequate. Further research is needed to continue 
investigating adult patient barriers to medical foods across the country. 
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Chapter 1 
Introduction 
Phenylketonuria (PKU) is an inborn error of metabolism that causes a deficiency in the 
enzyme phenylalanine hydroxylase which is essential for the conversion of phenylalanine 
into tyrosine. Without the function of this enzyme, the blood becomes saturated with 
phenylalanine and there is decreased production of the essential amino acid tyrosine 
(Vockley, Anderson, Antshel, Braverman, Burton, Frazier, Mitchell, Smith, Thompson, 
Berry, &; For the American College of Medical Genetics and Genomics Therapeutics 
Committee, 2014). Lower levels of tyrosine result in decreased production of dopamine 
causing neurological, behavioral, and psychological problems, as well as other medical 
implications. This includes hyperactivity, irritability, inability to sit, sleep disturbances, 
psychomotor agitation, uncontrollable attacks of rage, erratic or aggressive behavior, 
poor ability to learn new things, psychotic behavior, destructiveness, self-injury, self­
mutilation, autistic-like behavior, mental retardation, seizures, tremors, muscular 
hypertonicity or hypotonicity, spastic paraplegia, eczema, sensitivity to sunlight, and 
body odor (Brumm & Grant, 201 O; Dolan, Koch, Bekins, & Schuett, 2017; Jahja, van 
Spronsen, de Sonneville, van der Meere, Bosch, Hollak, Rubio-Gozalbo, Brouwers, 
Hofstede, de Vries, Janssen, van der Ploeg, Langendonk, & Huijbregts, 201 6). Increased 
amounts of phenylalanine also cause neurological damage as it changes the myelination 
of the white matter of the brain and inhibits other essential amino acids from crossing the 
blood brain barrier (Vockley et al., 2014). Due to the severity of this disorder, newborn 
screening protocols have been implemented in order to diagnose and treat individuals 
within the first two weeks of life (Vockley et al., 201 4). 
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The treatment of this disorder focuses on decreasing blood phenylalanine levels in 
an individual through the decreased consumption of phenylalanine in the diet (MacLeod 
& Ney, 2010; Vockley et al., 2014). This is achieved with a diet composed of foods 
naturally low in protein, such as frnits and vegetables; the incorporation of specialized 
low-protein medical foods; and a nutritional supplement, often in the form of a liquid 
formula or an alternative medical protein product. The supplement provides essential 
amino acids, vitamins, and minerals that are not available from natural sources. 
Individuals who do not maintain proper treatment are also at risk for neurological 
damage, further strengthening the need for individuals with PKU to maintain dietary 
treatment for life (Vockley et al., 2014). 
With this strict dietary protocol, individuals with PKU are only able to consume 
foods such as fruits and vegetables, and small amounts of low-protein snack and cracker 
items. They also have the complex task of measuring the amount of food consumed daily 
to determine the units of grams of dietary phenylalanine and total calories. The severity 
of the dietary restrictions, and required attention to detail often leads to compliance 
issues, which affect the overall nutritional statues and neurological development of the 
individual with PKU (Hafid & Christdoulou, 2015). In order to provide a wider variety of 
food choices, the use of low-protein medical foods has been incorporated into the dietary 
treatment of PKU. However, the price of these low-protein medical foods can cost a 
patient anywhere from $2,275 annually during the first few years of life to $ 1 2,438 at the 
beginning of adulthood (Huntington & Buist, 2009). 
Adult P KU Dietary Management 3 
Statement of the Problem 
The financial burden is one of the main barriers to managing the dietary needs of 
an adult with PKU. Insurance coverage and reimbursement for patients and families is 
often inconsistent and limited (Berry, Brown, Grant, Greene, Jurecki, Koch, Moseley, 
Suter, van Calcar, Wiles, Cederbaum, 2013a; Berry, Kenney, Harris, Singh, Cameron, 
Kraszewski, Levy-Fisch, Shuger, Greene, Lloyd-Puryear, & Boyle, 201 3b; Camp, Lloyd­
Puryear, & Huntington, 2012; Huntington & Buist, 2009; Weaver, Johnson, Singh, 
Wilcox, Lloyd-Puryear, & Watson, 2010). State mandates have been put in place to 
ensure that medical needs are being met, but there are "loopholes" that leave patients and 
families paying out of pocket for treatment expenses (Berry et al., 201 3b; Weaver et al., 
201 0). The insurance providers that do cover treatment needs usually set age limits, 
restricting access to coverage for most individuals over the age of 1 8  (Berry et al., 201 3a; 
Huntington & Buist, 2009; Weaver et al., 2010). However, PKU is a lifelong disease with 
treatment required for every age and stage of life. 
Purpose of the Study 
The purpose of this study was to identify the financial burdens associated with 
purchasing medical foods and the impact this has on the dietary management of adults 
withPKU. 
Significance of Study 
There have been very few studies conducted that research the financial aspects 
associated with maintaining the treatment of PKU. There is even less research that 
examines how adults with PKU are affected financially. This study helps identify how 
adults with PKU are affected financially while managing their dietary treatment. 
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Research Questions 
The following research questions guided this study. 
1. What were the financial responsibilities associated with managing the treatment 
of an adult with PKU in regard to purchasing medical foo<ls? 
2. To what extent does the state of residence, in regard to purchasing medical foods, 
influence the financial responsibilities associated with managing the treatment of 
an adult with PKU? 
3. To what extent does the purchase site of the medical foods influence the financial 
responsibilities associated with managing the treatment of an adult with PKU? 
4. To what extent do the financial responsibilities, in regard to purchasing medical 
foods, for the patient managing the treatment of PKU impact their dietary 
management? If so, how? 
Assumptions 
Several assumptions were made throughout this study. The researcher assumed 
PKU organizations and clinics would participate in this study and that participants would 
find this study interesting and relevant to their personal lives. A second assumption was 
that participants would be willing to complete the questionnaire due to potential long­
term benefits this may have for them as PKU patients. The researcher also assumed that 
participants would be able to read and comprehend the questionnaire and consent form. 
Finally, it was assumed that participants would answer questions honestly and to the best 
of their knowledge. 
Definition of Terms 
Terms used throughout this study include: 
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1 .  Medical food - a broad term describing three different components based on the 
Food and Drug Administration (FDA) definitions: medical formula, alternative 
medical protein products, and modified low-protein medical foods as energy 
sources and alternative energy products (Huntington & Buist, 2009). 
2. Medical formula- formulas designed as the main alternative to natural protein, 
but lacking selected nutrient( s) that must be restricted in the diet of persons with 
inborn errors of metabolism (Huntington & Buist, 2009). 
3. Alternative medical protein products - products excluding specific amino acids 
for the use of persons with inborn errors of metabolism and contain amino acids 
in a variety of forms: tablets, bars, gels, frozen sticks, and sauces (Huntington & 
Buist, 2009). 
4. Modified low-protein medical foods - "products that come in the form of baking 
mixes, pastas, rice, sauces, and premade items that are designed to be as similar to 
their normal counterparts as possible, but supply negligible protein" (Huntington 
& Buist, 2009). 
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Chapter 2 
Review of Literature 
This section presents the current literature related to the management of PKU, 
including disease diagnosis and progression, the dielary management required to treat 
PKU, consequences of untreated or undiagnosed patients, the different treatment options 
available, and insurance coverage discrepancies that can negatively impact the treatment 
ofPKU. 
Disease Diagnosis and Progression 
PKU is an inherited autosomal recessive disorder that hinders the metabolism of 
phenylalanine (Vockley et al., 2014). This genetic disorder results from both parents 
being carriers of the gene. According to the National PKU Alliance [NPKUA] (201 6a), 
the prevalence of being a carrier of the gene is 1 in 50, and the likelihood of two carriers 
having a child together is about 1 in 2,500. When both parents are carriers of the gene, 
there is a 25% chance that their child will have PKU (Mitchell, Trakadis & Scriver, 
2011). While PKU is extremely rare, it is considered one of the most common inborn 
errors of metabolism affecting 1 in every 10,000-1 5,000 births (Vockley et al., 2014). Of 
the 3.2 million people in the United States, there are about 15,000 people who have PKU 
(United States Census Bureau, 20 1 6; Vockley et al., 2014). 
Individuals with PKU have a deficiency of the phenylalanine hydroxylase 
enzyme, which is responsible for the conversion of the amino acid phenylalanine into 
another amino acid, tyrosine. Phenylalanine is obtained through dietary protein as well as 
through transamination, which result in an endogenous protein source (Mitchell et al., 
2011; Vockley et al., 20 14  ). The metabolic pathway of phenylalanine catabolism is 
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essential because tyrosine is an amino acid that cannot be produced by the body and must 
be obtained from food through the conversion of phenylalanine. The deficiency of the 
phenylalanine hydroxylase enzyme causes a decreased production of tyrosine and a build 
up of phenylalanine. If PKU is left undiagnosed or untreated these nutrient imbalances 
will cause severe and irreversible behavioral, psychological, and neurological problems, 
such as hyperactivity, irritability, inability to sit, sleep disturbances, psychomotor 
agitation, uncontrollable attacks of rage, erratic or aggressive behavior, poor ability to 
learn new things, psychotic behavior, destructiveness, self-injury, self-mutilation, 
autistic-like behavior, mental retardation, seizures, tremors, muscular hypertonicity or 
hypotonicity, spastic paraplegia, eczema, sensitivity to sunlight, and body odor (Brumm 
& Grant, 2010; Dolan et al., 2017; Jahja et al., 2016; Mitchell et al., 201 1; Vockley et al., 
2014 ) . Thus, further strengthening the necessity to maintain the dietary treatment for life 
(). The consequences of an individual with PKU being undiagnosed or untreated was 
unacceptable for Dr. Robert Guthrie, as his son was born with developmental disabilities 
and his niece was diagnosed with PKU (Koch, 1997). 
In the 1960' s, Dr. Guthrie developed the bacterial inhibition assay test that could 
detect high levels of phenylalanine in patients' blood (Koch, 1997; Mitchell et al., 201 1; 
Vockley et al., 2014). When the blood is drawn, the amount of phenylalanine 
concentration is tested to determine the presence and severity of PKU. This test was used 
to screen newborns shortly after birth in order to provide an early diagnosis and prevent 
future brain damage (Koch, 1997; Mitchell, 20 11  ). Eventually, this test influenced the 
development of newborn screening tests for other inborn errors of metabolism, which is 
now a Federal policy that newborns be screened. 
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Testing has now advanced to analyzing the specific genetic mutation of the 
phenylalanine hydroxy lase enzyme associated with PKU. Analysis of the genetic 
mutation is not a standard of care, but according to the American College of Medical 
Genetics and Genomics (ACMG) Practice Guidelines, recommendations include that 
individuals get tested (Vockley et al., 2014). Understanding the genetic mutation of 
individuals with PKU will provide a better understanding about PKU and promote further 
research into new treatments (Mitchell, 2011). Depending on the type of genetic 
mutation, individuals with PKU have different tolerance levels of phenylalanine (NIH 
U.S. National Library of Medicine, 2017; Vockley et al., 2014). 
PKU can be separated into four different classifications based on the severity of 
the disorder: classic PKU, moderate PKU, mild PKU, and mild hyperphenylalaninemia 
(MHP). The most common and severe form of PKU is called classic PKU (Blau, van 
Spronsen, & Levy, 2010; Mitchell et al., 2011; Vockley et al., 2014). Individuals with 
classic PKU are identified as having severely reduced or absent enzyme activity and 
blood phenylalanine levels greater than 1200 umol/L or 20 mg/dL while normal 
phenylalanine levels are 60 umol/L or 1 mg/dL (Blau et al., 201 O; Mitchell et al., 2011; 
Vockley et al., 2014). Moderate PKU is considered a moderate level of the disorder with 
a phenylalanine concentration range of 900-1200 umol/l or 15-20 mg/dL. Mild PKU is 
classified as having blood phenylalanine levels with a range of 600-900 umol/L or 10-15 
mg/dL, and MHP the lowest level of PKU with phenylalanine levels ranging from 120-
600 umol/L or 2-1 Omg/dL (Blau et al., 2010). The less severe forms of PKU including 
moderate PKU, mild PKU, and MHP have some enzyme activity, which is why 
phenylalanine tolerance is higher than classic PKU. 
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Dietary Treatment of PKU 
The treatment of PKU requires individualized medical nutrition therapy that 
restricts the intake of dietary phenylalanine (MacLeod & Ney, 2010). Due to the 
spectrum ofthis disorder, every patient's dietary phenylalanine tolerance differs from 
each other. Patients with classic PKU can tolerate no more than 250-350 mg of dietary 
phenylalanine, whereas patients with MHP PKU have little to no restriction with 
phenylalanine intake. Individuals with MHP PKU are able to maintain plasma 
phenylalanine concentrations less than 600 �tmol/L on a normal diet (Mitchell et al., 
2011 ). According to guidelines, dietary phenylalanine intake may change depending on 
age and gender (MacLeod & Ney, 2010). A metabolic physician and registered dietitian 
nutritionist determine the specific amount of dietary phenylalanine a patient is allowed to 
consume per day, in order to keep plasma phenylalanine concentrations within the 
therapeutic range of 120-360 µmol/L (2-6 mg/dL) (MacLeod & Ney, 2010; Vockley et 
al., 2014). 
Table 1 
Recommended Dietary Phenylalanine Intake Based on Diagnosis 
Diagnosis Diagnostic Plasma Phenylalanine Recommended Dietary 
Concentration Phenylalanine Intake 
Classic > 1200 µmol/L (20 mg/dL) <250-350 mg 
Moderate 900-120 µmol/L (15-20 mg/dL) 350-400 mg 
Mild 600-900 µmol/L ( 10-15 mg/dL) 400-600 mg 
MHP 120-600 µmol/L (2-10 mg/dL) Little to no restriction 
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Dietary Management. Parents are tasked with extra and unfamiliar 
responsibilities for caring for their child from day one. Immediately following diagnosis, 
generally around 8- 1 0  days old, measuring and recording the amount of food consumed 
each day is essential in order tu track the intake of phenylalanine. This can be achieved 
using the book, "Low protein food list for PKU", or using the app, "How Much Phe?" 
(Schuett, 2010). Both of these products give patients and families the phenylalanine 
content in foods and beverages. Along with daily monitoring of food intake, patients are 
required to send in monthly blood samples using a dried blood spot test in order to assess 
phenylalanine concentration (Vockley, 2014; Williams, Mamotte, & Burnett, 2008). 
Patients are also required to attend annual outpatient clinic visits from their physician, 
dietitian, and any other necessary health professionals. This visit includes a dietary 
check-up involving a 24-hour food recall, a routine blood phenylalanine and tyrosine 
analysis, and an overall examination from the physician checking for physical signs of 
noncompliance with the diet such as hand or tongue tremors (MacLeod & Ney, 201 0; 
Vockley, 2014; Willaims et al., 2008). 
Components of PKU Diet. In order to satisfy nutritional needs, patients need to use a 
phenylalanine-free synthetic medical formula that is fortified with amino acids, calories, 
fat, vitamins, and minerals (MacLeod & Ney, 2010; Rohde, von Teeffelen-Heithoff, 
Thiele, Arelin, Miltze, & Kiener, Gerloff, Baewald, Schultz, Heller, Muller, Kiess, & 
Beblo, 2013; Vockley et al., 2014). Depending on the nutritional composition of the 
medical formula product prescribed, physicians may also recommend additional vitamin 
and mineral supplementation. Without consumption of medical food products, patients 
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could develop extreme nutrient deficiencies (Macleod & Ney, 2010; Rohde et al., 2013; 
Vockley et al., 2014). 
Alternative medical protein products have been recently introduced as new 
sources of protein as well. Like the medical formulas, these products also contain the 
necessary amino acids and nutrients required for treatment. However, these products are 
in the form of tablets, bars, gels, sauces, and frozen sticks (Huntington & Buist, 2009; 
MacDonald, 2000). Gylcomacropeptide (GMP) products are an alternative medical 
protein product that is popular among individuals with PKU. 
GMP is a whey protein that naturally occurs in bovine milk and does not contain 
phenylalanine. However, GMP comes from cheese whey and when isolated, it becomes 
contaminated with b-lactoglobulin and a-lactalbumin (Hafid & Christodoulou, 2015; 
MacLeod & Ney, 2010; van Calcar & Ney, 2012). Both of these contain phenylalanine, 
which results in 2-5 mg of phenylalanine per gram of protein in commercially sold GMP 
products (van Calcar & Ney, 2012). According to Macleod & Ney (2010), GMP foods 
and beverages will ultimately result in 5-15 g of protein and 15-25 mg of phenylalanine. 
For someone with classic PKU, who is allotted Jess than 350 mg phenylalanine, this 
amount of dietary phenylalanine would still be within the therapeutic range. 
GMP products also offer an increase in protein retention and utilization compared 
to that of a synthetic amino acid-based diet (i.e. use of medical formula). Patients using 
GMP products as their source of nutrients receive about 70% of protein needs from the 
intact protein in GMP, fruits and vegetables. The other 30% of protein needs are from 
supplemented synthetic amino acids found in alternative medical products or medical 
formula (Macleod & Ney, 2010; van Calcar & Ney, 20 12). ln contrast, patients on an 
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amino acid-based diet receive only 20% of protein needs from intact protein found in 
fruits and vegetables. The remaining 80% is from the supplemented synthetic amino 
acids (MacLeod & Ney, 2010; van Calcar & Ney, 2012). Overall, GMP products, along 
with other alternative medical protein products, offer patients an effective way to achieve 
normal growth and health maintenance (Hafid & Christodoulou, 20 1 5; Huntington & 
Buist, 2009; MacDonald, 2000; MacLeod & Ney, 2010; van Calcar & Ney, 2012). 
Modified low-protein medical foods are also used in the treatment of PKU. 
Individuals with PKU are restricted from consuming natural sources of protein. 
Maintaining a severely restricted diet for a long period of time is extremely difficult. 
Even non-PKU individuals who voluntarily limit their food intake for personal reasons 
struggle with diet maintenance. Patients with PKU have dietary limitations throughout 
the duration of their life, but unlike non-PKU persons, they do not have the option to stop 
dietary treatment without suffering from severe health consequences. Modified low­
protein products offer patients a variety of food choices including, but not limited to, 
breads, cereals, baking mixes, meat alternatives, and pastas (Cambrooke Therapeutics, 
2016). These medical foods also provide patients with additional calories and satiety 
(Vockley, 2014). 
Consequences of PKU Diet. Reducing dietary phenylalanine intake requires patients to 
decrease the intake of natural protein sources, which includes the elimination of meat, 
fish, poultry, egg, milk, grain, legume, and nut products, as well as limited consumption 
of higher protein vegetable items (MacLeod & Ney, 2010). This leaves patients 
consuming a diet of low-protein vegetables, fruits, and foods that are high in sugar and 
fat. The PKU diet is lacking a majority of natural food sources putting patients at a higher 
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risk for nutrient deficiencies (Hafid & Christodoulou, 2015; MacLeod & Ney, 2010; 
Robert, Rocha, van Rijn, Ahring, Belanger-Quintana, MacDonald, Dokoupil, Gokmen, 
Lannardo, Goyens, & Feillet, 2013; Rohde et al., 2013). 
Vockley et al. (2014) states the impo1tance of assessing the nutrient status of 
patients routinely through tests including a full panel of plasma amino acids, albumin, 
complete blood count, ferritin, vitamin D, vitamin B 12, essential fatty acids, trace 
minerals, vitamin A, and a comprehensive metabolic panel. Vockley et al (2014) also 
recommends implementing routine DEXA scans to monitor bone density. Common 
nutrient deficiencies seen in patients with PKU include vitamin B6, B 12, folate, calcium 
and iron. Individuals following the PKU diet also consume less total fat compared to a 
regular diet. This leads to a decreased consumption of long-chain polyunsaturated fatty 
acids (LC-PUFAs). Docosa-hexaenoic acid (DHA) is especially important because this 
LC-PUFA supports normal brain and visual development (MacLeod & Ney, 2010). 
Adequate intake of folate, vitamin B6, and B 12 are also important due to their role in 
reducing the risk of thrombosis, atherosclerosis, and stroke (Hafid & Christodoulou, 
2015; MacLeod & Ney, 201 O; Robert et al., 2013). PKU patients also have a higher risk 
of osteopenia, osteoporosis, and fractures. Researchers are unclear whether this is the 
result of an individual's genotype or poor utilization and absorption of phosphorus, 
calcium, and vitamin D, but consumption of adequate levels of these nutrients are vital to 
compensate for reduced absorption and metabolism associated with an elemental diet and 
to prevent future complications (Hafid & Christodoulou, 2015; MacLeod & Ney, 2010). 
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Barriers of PKU Diet 
In order to decrease the risk of the developing nutrient deficiencies and 
neurological dysfunction, individuals with PKU are required to follow strict dietary 
gui<ldin�s (Halid &Christodoulou, 2015; MacLeod & Ney, 2010; Vockley et al ., 201 4). 
However, managing the dietary treatment of PKU is very challenging. There are multiple 
barriers to overcome in order to successfully achieve and maintain proper dietary 
treatment including compliance issues, high cost of medical foods, and seemingly 
inadequate insurance coverage (National Organization for Rare Disorders [NORD], 2015; 
Berry et al., 2013a; Berry et al., 2013b; Camp, Lloyd-Puryear, & Huntington, 2012; 
Hafifd & Christodoulou, 2015; Huntington & Buist, 2009; MacLeod & Ney, 2010; 
Weaver et al., 2010). These barriers are especially difficult for adult patients with PKU 
(Berry et al., 2013a; Berry et al., 2013b; Hanley, 2004; MacLeod, & Ney, 2010; Schuett, 
Gurda, Brown, 1 980). 
Compliance Issues. Compliance with the prescribed dietary treatment is 
extremely important in order to avoid any cognitive or nutrient deficits. Dietary 
compliance starts with learning management skills and responsibilities and implementing 
these practices at a young age. However, children often face challenges with compliance 
as they grow older due to peer influences, independence of food selection, and developed 
taste preferences (MacLeod & Ney, 2010). The three main reasons for noncompliance in 
individuals with PKU include age of maintaining dietary treatment, palatability, and 
social influences. 
Children with poor management skills experience greater challenges complying 
with dietary restrictions through adulthood. MacLeod and Ney (2010) describe how 
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challenging it can be for adults trying to re-establish the low phenylalanine diet after 
periods of noncompliance. Since an adult with PKU does not show physical symptoms or 
an immediate reaction the same way someone with a food allergy does, the primary cause 
for discontinuing the diet was decreased motivation (MacLeod and Ney, 2010; Schuett, 
Gurda, & Brown, 1980). While noncompliance during adulthood may not cause 
irreversible damage the same way it does during childhood, it does still cause 
neurological problems including irritability, increased incidence of anxiety and 
depression, difficulty concentrating, and headaches (Brumm & Grant, 2010; Jahja et al., 
2016; Hafid & Christodoulou, 2015; MacLeod & Ney, 2010; Vockley, 2014). 
Adults who have experienced long-term noncompliance are more likely to be 
born before 1970. Schuett, Gurda, & Brown conducted a study in 1980 that examined the 
diet discontinuation policies and practices of PKU clinics in the U.S. The results 
indicated that policies of PKU clinics varied widely across the country. 
Recommendations included that children over the age of I 0 stop dietary treatment 
altogether (Schuett, Gurda, & Brown, 1980). For patients who grew up believing that 
treatment cessation was acceptable, reinstituting the low phenylalanine diet is even more 
difficult (Macleod & Ney, 2010). 
Another reason for noncompliance is the palatability of the diet (Hafid & 
Christodoulou, 2015; van Calcar & Ney, 2012). The synthetic amino acid medical 
formula is a challenge for some patients to consume due to the taste of the products. 
MacDonald (2000) reported that 20% of adult patients had stopped consuming the 
prescribed protein substitute, but were still following a low phenylalanine diet. Multiple 
studies have shown low levels of acceptability for the prescribed protein substitutes, 
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especially among adults (Kemper, Brewer, & Singh, 2010; MacDonald, 2000). Kemper, 
Brewer, & Singh (2010) conducted a study evaluating the perspectives of dietary 
adherence among women with inborn errors of metabolism and identified common 
themes of barriers to dietary adherence such as taste, social isolation, and expense. 
Results indicated participants reporting decreased acceptance of taste and smell of the 
medical formulas and modified low-protein foods (Kemper, Brewer, & Singh, 2010). 
New products have been created in order to help improve the taste, thus 
increasing diet acceptance (van Calcar and Ney, 2012). Medical formulas now come in a 
variety of brands and flavors. Alternative medical protein products such as bars, tablets, 
capsules, gels, and other flavored powders and beverages have been introduced into the 
diet as well. GMP products were evaluated based on appearance, odor, taste, texture, and 
overall acceptability with scores indicating positive responses. "Ten of 11 subjects 
believed the GMP foods were better tasting and added variety to the low phenylalanine 
diet compared with their usual amino acid formula" (van Calcar & Ney, 2012, p. 6). 
Alternative medical protein products are proving to be even more beneficial for adults 
because the daily consumption of formula in place of food has shown to be challenging 
for patients as they age (van Calcar & Ney, 2012). 
Mealtimes are another challenge for compliance with the diet (MacDonal, 2000). 
Individuals with PKU cannot eat a majority of food included in a typical American diet. 
Dining at restaurants is even more challenging due to the limited menu options. French 
fries, baked potatoes, salad, and other side vegetables may be the only options individuals 
with PKU can choose from. Depending on the individual's confidence or beliefs about 
the diet, having such restrictions can cause feelings of isolation or "being different" 
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(MacDonald, 2000). Modified low-protein medical foods not only provide nutritional 
support, but can offer the sense of inclusion. Individuals would be able to enjoy bread, 
pastas, baked goods, meat alternatives, and other substitute foods with the rest of their 
families and friends (Cochrane, Schwahn, Galloway, Robinson, & Gerasimidis, 2014; 
MacDonald, 2000). Kemper, Brewer, and Singh (2009) found that patients with inborn 
errors or metabolism appreciated having low-protein medical foods during social 
gatherings and around other peers. Cochrane et al (2014) conducted a study exploring 
patient's beliefs and acceptability of modified low-protein medical foods and found that 
78% of adult patients reported using low-protein foods to add variety in their diet and 
74% of adult patients reported that using low-protein foods helped satisfy their appetite. 
Medical foods are not onJy used to provide adequate nutrition, but have been proven to 
help overcome compliance issues with the extremely strict dietary treatment of PKU. 
However, access to medical foods is challenging for most patients, and is even harder for 
adults to obtain due to increased cost and lack of insurance coverage 
Cost of Medical Foods. The cost of medical foods causes a financial burden on 
most individuals and families with PKU. Huntington & Buist (2009) estimated the 
average annual cost of medical formula increases from $2,275 during infancy to $12,483 
at the age of 1 8. This is an average cost of about $7, 100 per year and $220,000 from 
infancy through the age of 24 years, which does not include the cost of alternative protein 
products or modified low-protein medical foods. Medical formula is not easily affordable 
as the wholesale cost is about 30% higher than the retail cost of regular infant formula 
(Huntington & Buist, 2009). This is an issue because most non-PKU families stop 
purchasing infant formula after about 6 months to 2 years of age, whereas families and 
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patients with PKU need medical formula for their entire life. The continuous increase in 
cost of medical formula is hindering for patients as they get older and adds greater stress 
for compliance as they are already faced with other additional barriers. 
According to Huntington and Buist (2009), the use of low-protein medical foods 
is necessary to include in the PKU diet as a source of energy because the amino acid 
products, i.e. medical formulas, are the most expensive products and too costly to be used 
as the main energy source. Using medical formula as the primary energy source was 
calculated to cost 1 70% more than the use of low-protein medical foods combined with 
the medical formula, which is a difference of more than $8,000 per year (Huntington & 
Buist, 2009). However, modified low-protein medical foods are also expensive, with 
these low-protein food products costing anywhere from 2 to 8 times more than the retail 
cost of the regular counterpart food items. For example, the retail cost of spaghetti is 
$0.37 per I 00 grams and the wholesale cost of low-protein pasta is $2.20 per 100 grams 
(Huntington & Buist, 2009). The cost of low-protein medical foods is also going to cost 
more than regular food items due to supply and demand. There are only 1 6,445 patients 
in the United States requiring low-protein medical foods, which results in a significant 
marku p o f  c o st .  
Since the demand for low-protein food items is  so low, these products are often 
not supplied in commercial grocery stores, leaving families and individuals no choice but 
to make purchases through third-party companies and pharmacies, further increasing the 
cost (Camp, Lloyd-Puryear, & Huntington, 2012; Huntington & Buist, 2009). Retail 
prices are higher than wholesale prices, and pharmacies typically add a markup of 200% 
to 300% of wholesale cost (Camp, Lloyd-Puryear, & Huntington, 2012; Huntington & 
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Buist; 2009). Furthermore, most third-party companies are online stores with policies 
requiring a minimum cost of purchase (Cambrooke Therapeutics, 2016). For example, 
Cambrooke Therapeutics, a popular PKU food distributor, requires a minimum purchase 
of $50 for any cold shipped items and a minimum of $30 for any dry shipped items. After 
making that minimum purchase, shipping rates ranging anywhere from $40-$50 still 
apply ( Cambrooke Therapeutics, 2016). 
Inadequacies of Health Care Coverage. The high cost of medical foods is of 
significant concern because unlike most treatments or prescriptions, PKU medical foods 
are not adequately covered by health insurance, leaving most patients and families to pay 
out-of-pocket (Berry et al., 201 3a; Berry et al., 2013b; Camp, Lloyd-Puryear, & 
Huntington, 201 2; Huntington & Buist, 2009; Kemper, Brewer, & Singh, 2010; Weaver 
et al., 2010). Berry et al. (2013b) found that 60% of parents with children of inborn errors 
of metabolism paid for modified low-protein foods out-of-pocket, with 48% paying more 
than $100 per month and 5% paying more than $500 per month. 
One of the main problems contributing to lack of health care coverage for patients 
with PKU is the way medical foods are defined. The Food and Drug Administration 
(FDA) defines a medical food as "a food whjch is formulated to be consumed or 
administered enterally under the supervision of a physician and which is intended for the 
specific dietary management of a disease or condition for which distinctive nutritional 
requirements based on recognized scientific principles are established by medical 
evaluation" (section 5(b) of the Orphan Drug Act [2] U.S.C 360ee (b) (3)]). This 
definition is inadequate because it describes medical food closer to that of general food 
than that of a prescription or treatment. According to Weaver et al. (2010), the FDA 
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could not define medical foods as pharmaceutical agents be cause the population of 
diso rders treate d by medi cal foods w as too s mall to perform clinical trials, in part due to 
ethical considerations. Since, by the FDA's definition, medical foods are not considered 
pharmaceutical agents, there is no need for a doctor's p rescription, which is one re ason 
insurance companies are not required to provide reimbursement or coverage (Weaver et 
al., 2010). 
Language is also an issue regarding state policies and mandates. State policies and 
mandates are put in place to ens ure that health care needs are being met. "The main 
themes addressed in the laws include (1) who is responsible for cove ring the individual 
(e.g. health insurance, health de p artment, or state funds), (2) what disorder(s) is/are 
covered, (3) the benefit limit of what is covered, ( 4) whether the medical food must be 
order by a physician, (5) until what age the coverage is applicable, (6) whether 
deductibles and copayments are applicable, and (7) income eligibility requirements for 
public programs" (Weaver et al., 2010, p. 366). State policies and mandates are different 
across the country though with some states using specific terms and defini tions, while 
other states using broader terms and definitions. Due to the variability of coverage, some 
states pro vi de diffe rent coverage th an others and even families w ithi n  the same state may 
re ceive different coverage (Huntington & Buist, 2009; Weaver et al., 2010). 
The administrative language used for coding health services is also inadequate. 
Insurance companies evaluate reimbursement eligibil ity based on a system of coding. 
PKU would be classified under inborn errors of metabolism, but there are no classified 
codes for this category of disorders (Huntington & Buist, 2009). B codes and S codes are 
used as replacement codes, however, they do n o t  properly define the products and 
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services utilized. The three types of B codes specify administration of medical foods 
enterally (Huntington & Buist, 2009). Unless a patient with PKU has a specific need for 
enteral or parenteral tube feedings, medical foods are consumed orally. The two S codes 
used arc more appropr iate in definition, but can only be successfully us ed in a small 
number of states because certain providers don't recognize it for reimbursement 
(Huntington & Buist, 2009). This aligns with the variability of language with state 
policies and mandates. 
Medicare, ERISA, and TRICARE regulations impact state mandates that decrease 
eligibility status for health care coverage. Most patients with PKU consume medical 
foods orally, unless required otherwise as directed by a physician, and Medicare does not 
provide coverage for enteral solutions (e.g. medical formula) unless administered 
enterally. ERISA is an act that abolished state regulation of employee benefit plans 
through self-insured employers (Huntington and Buist, 2009). Employment-based health 
plans provide private insurance coverage and because of ERISA, these plans are exempt 
from state insurance laws. TRICARE is a federal insurance program provided for U.S. 
Armed Forces military personnel and military retirees that is also exempt from state 
insurance laws, but this year a bill was p assed from the House to in cludes the use of 
medical foods for treatment and management of rare disorders, including PKU (National 
PKU Alliance, 2016b). The passing of this bill will help raise awareness to other 
insurance providers about the importance of coverage of medical foods for patients with 
PKU and other inborn errors of metabolism. 
Access to health care coverage for adults with PKU is especially difficult because 
state and private insurance companies usually have a designated age cutoff at 18 to 2 1  
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years of age (Berry et al., 2013b; Hanley, 2004; Huntington & Buist, 2009; Weaver et al., 
2010). Berry et al. (20 13a) examined the mandated coverage of treatment for adults with 
PKU by state and found only 8 states provided coverage for medical formula. Twenty­
five states covered medical formula and low-protein medical foods and 1 state covered 
the use oflow-protein medical foods only (Berry et al., 2013a). Six states only had 
pediatric mandates in place and of those 6 states, l state indicated a cutoff age of 24 
years. Overall, 18 states did not include mandates about health care coverage for adults 
with PKU and 30 states did have mandates in place (Berry et al., 201 3a). However, even 
with state mandates in place for adult health care coverage, the variability of language 
used in creating these policies may deny adults eligibility for coverage or reimbursement 
(Berry et al., 20 1 3a; Huntington & Buist, 2009; Weaver et al., 2010). 
Quality access to and health care coverage of medical foods is important for the 
management of PKU. Kemper, Brewer, & Singh (2010) found that women with inborn 
errors of metabolism indicated that lack of insurance coverage led to compliance issues. 
Without insurance coverage for medical foods, participants reported not having adequate 
access to food and thus, would be tempted to eat foods higher in protein that were more 
readily available. 
Conclusion 
In summary, compliance with the diet, cost of medical foods, and inadequate 
health care coverage are all barriers associated with managing the dietary treatment of 
PKU as an adult. Medical foods help support dietary adherence due to improving taste, 
palatability, and sense of social inclusion and acceptance (Hafid & Christodoulou, 2015; 
Kemper, Brewer, & Singh, 2010; MacDonald, 2000; van Calcar & Ney, 2012). The cost 
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of medical foods is extremely expensive compared to the cost of regular foods and there 
is a lack of health care coverage for most adults, which restricts access to necessary 
treatment (Berry et al., 201 3a; Berry et al., 2013b; Camp, Lloyd-Puryear, & Huntington, 
2012; Huntington & Buist, 2009; Kemper, Brewer, & Singh, 2010; Weaver et al., 2010). 
The inadequate access to medical foods dangerously hinders dietary compliance and 
leads to other health complications such as nutrient deficiencies and neurological 
problems, further solidifying the need to address these financial burdens associated with 
managing PKU dietary needs as an adult (Brumm & Grant, 2010; Jahja et al., 2016; 
Hafid & Christodoulou, 2015; Macleod & Ney, 2010; Vockely, 2014). 
Chapter 3 
Methodology 
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The purpose of this study was to identify the financial burdens associated with 
p u rchasing medical foods and the impact thi s has on the dietary management of adults 
with PKU. Four research questions guided this research study : 
1. What were the financial responsibilities associated with managing the treatment 
of an adult with PKU in regard to purchasing medical foods? 
2. To what extent does the state of residence, in regard to purchasing medical foods, 
influence the financial responsibilities associated with managing the treatment of 
an adult with PKU? 
3.  To what extent does the purchase site of the medical foods influence the financial 
responsibilities associated with managing the treatment of an adult with PKU? 
4. To what extent do the financial responsibilities, in regard to purchasing medical 
foods, for the patient managing the treatment of PKU impact their dietary 
management? If so, how? 
Research Design 
The design of this study was a mixed method, non-exper imental , survey design 
using an online questionnaire to identify different financial barriers associated with the 
cost, PKU treatment modalities and how identified barriers affect the management of the 
medical nutrition therapy in adults with PKU. Currently there are no standards for health 
care coverage and each state has its own mandates about providing insurance coverage, 
reimbursement, and any other type of financial assistance (NORD, 2015). Missouri and 
Illinois are two states that offer different financial assistance for those diagnosed with 
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PKU, which is why the financial barriers for adult with PKU were examined in both 
Missouri and Illinois. Permission to conduct this study was obtained from Eastern Illinois 
University Institutional Review Board (IRB number 16-1 27). 
Sample 
A non-probability, purposive sample was used due to the focus of this study 
evaluating individuals with PKU. The original sample size was intended to be between 50 
and I 00 participants in total from both Missouri and Illinois. There are currently no 
reports indicating the population of adult PKU patients per state, so this was a very rough 
estimate of how many adults with PKU might participate. 
Recruitment. Recruitment of prospective subjects first started with recruiting 
participation from registered dietitians and board members (point persons) from PKU 
organizations and clinics in Missouri and Illinois. Due to HIPP A laws, point person 
participation was vital in order to send out the survey to PKU patients. Point persons 
from the NPKUA, the PKU Organization of Illinois, the University of Illinois at Chicago 
Medical Center, RUSH Hospital, Lurie Children's Memorial Hospital, St. Louis 
Children's Hospital, SSM Health Cardinal Glennon Children's Hospital, and the 
University of Missouri Health Care were contacted via email by the researcher explaining 
the purpose of the study and the importance of participation. Each hospital selected has a 
known PKU clinic, and the organizations listed are widely known community 
organizations involved in supporting families and individuals with PKU. Due to the small 
population of adults with PKU, a point person from the University of Iowa Hospitals and 
Clinics was also recruited to establish a sample for a pilot study. Establishing point 
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person participation required IRB approval from both the Eastern Illinois University and 
the participating hospital. 
Recruitment of prospective subjects occurred after participation of point persons 
were confirmed. An email was distributed to each participating point person that was to 
be forwarded to patients and members of hospitals and organizations. The email invited 
anyone with PKU who was 1 8  years of age or older to take the anonymous survey. The 
email included how this study could benefit participants directly, included a link to the 
online questionnaire, and listed contact information for anyone that had questions or 
concerns about the study or survey. Participants were excluded from the study if they 
were not from Missouri or Illinois, and if they were a parent of a child with PKU. 
Instrumentation 
The data collection instrument was an anonymous online questionnaire survey. 
The questionnaire was adapted from an existing questionnaire survey that was used in a 
study called, "Insurance coverage of medical foods for treatment of inherited metabolic 
disorders", created by Berry et al. (2013b). The questionnaire survey from Berry et al. 
(2013b) was developed in four different regions of the nation and then piloted in two 
centers in different regions. Family focus groups were held and the questions were 
refined based on provided feedback. A medical food reference list was also included in 
the survey to aid in responding to questions (Berry et al., 2013b). The validity and 
reliability of this tool was not discussed in the research article, nor was it disclosed to the 
researcher. 
Modifications were made to the pre-existing questionnaire in order to meet the 
needs of this study. A Likert-type scale was included in the questionnaire in order to 
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evaluate the individual's perception of the financial burdens related to purchasing 
medical foods, with the medical food reference list not included based on the purposes of 
this study. Once the questionnaire was completed, a committee of three professors 
reviewed the i nstrument to ensure face validity. Reliability was not determined. 
Upon opening the link to the survey, individuals were prompted with information 
about consent to participate in the study before proceeding to the questions. Participants 
were reminded that the survey was anonymous and advised them of any protentional 
discomfort that may arise due to the personal nature of the questions. If individuals 
agreed with the terms of informed consent, they could choose to continue to the 
following questions within the survey. If individuals did not agree with the terms of 
participation, they were given the opportunity to leave the survey by exiting out of the 
browser. Participants were also given the option to withdrawal from the study at any 
point and confirmed that answers were not saved or utilized until completion of the study 
was submitted. 
Within the survey (see Appendix A), the three different types of medical foods 
(i.e. medical formula, alternative medical protein products, and low-protein medical 
foods) were defined for participants. This was important to establish because every state 
has a varying definition for the term medical food, which overall affects the type of 
coverage provided (NORD, 2015). Each question was specific about the type of medical 
food. 
The survey consisted of six questions divided into three sections labeled A, B, and 
C. Section A examined the participants' source of medical foods. The first question 
verified state of residence and the second question assessed purchase site of medical 
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foods. Section B included questions pertaining to the payment of medical foods such as 
how products are paid for, how much insurance pays and how much participants pay out­
of-pocket. Lastly, Section C included a Likert-type scale evaluating participants' 
perceptions about their health care coverage and dietary management. At the end of the 
questionnaire, space was provided for participants to leave additional comments about the 
survey or their personal experiences with health care coverage for the treatment of PKU. 
Pilot Study 
A pilot study was conducted for this research in December 2016 using Qualtrics. 
The purpose of the pilot study was to evaluate the duration of the study, and the clarity 
and readability of the questions. After the final question of the survey, participants were 
redirected to questions about completion the survey. Face validity of the pilot study 
questions were reviewed by a committee of three professors. Reliability was not 
determined. If participants did not agree that the survey was clearly written or easy to 
understand, they were prompted with follow-up questions indicating which questions 
were an issue. There was also additional space for participants to leave comments or 
suggestions about clarification of instructions or improvement of format of the survey. 
The survey was piloted with five patients from the University of Iowa Hospitals and 
Clinics. The survey reportedly took patients about five to ten minutes to complete. All 
five patients agreed that the survey was clearly written and easy to understand. Only one 
participant made suggestions and adjustments were made accordingly. 
Data Collection 
Of the eight PKU organizations and clinics, three agreed to participate in this 
study. Data collection occurred over the span of two weeks, however, the survey was 
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opened at three separate occasions to accommodate to the needs of the point persons 
regarding IRB approval from their facility. The survey was first opened to patients at 
Cardinal Glennon Children's Hospital in December 2016. The second opening of the 
survey occurred between January and February 2017 for patients at Lurie Children's 
Memorial Hospital. The third and final opening of the survey was in February 201 7  for 
members of the PKU Organization of Illinois. The survey was opened over a two-week 
time frame to ensure potential participants had enough time to receive the invitation 
email and complete the survey. 
First, the invitation email was sent to the point person the night before the survey 
opened. Point persons were then able to distribute the invitation email to their adult 
patients and members. After one week of opening the online survey, a follow-up email 
was sent to the point person from each organization and hospital asking to forward 
reminders about participation in the survey. A final follow-up email was sent as another 
reminder for participation in the survey 24 hours before closing the survey. At the end of 
the two weeks from the final survey opening, the researcher assessed each participant's 
response to the questionnaire. 
Data Analysis 
Data were analyzed using basic descriptive statistics, which was achieved through 
reports from Qualtrics. Data were exported from Qualtrics and imported into Microsoft 
Excel. Responses to questions in sections A and B were analyzed using a measure of 
frequencies and percentage statistics. Data from survey item 5 was not reported due to the 
number of null responses. Responses to questions in section C were based on a Likert­
type scale and were analyzed by a mean of the responses to each question. At the end of 
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the questionnaire there was space for participant s to leave additional comments regar ding 
their thoughts and opinions. Any additional comments were anal y zed comprehensive ly i n  
or der to deter mine main themes from e ach re sponse . 
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Chapter 4 
Results and Discussion 
The purpose of this study was to identify the financial burdens associated with 
purchasing medical foods and the impact this has on the dietary management of adults 
with PKU. An online questionnaire including six questions and Likert-type scale was 
used to evaluate the financial barriers and responsibilities of adults with PKU. 
Participation 
Of the eight PKU organizations and hospitals that were sent email invitations, 
three agreed to participate in the study and shared the survey link to their patients and 
members. Cardinal Glennon Children's Hospital represented individuals in Missouri, and 
Lurie Children's Memorial Hospital and the PKU Organization of Illinois represented 
individuals in Illinois. The number of adult PKU patients and members of each hospital 
and organization is unknown, however, a total of 45 responses were recorded. Of the 45 
responses, 24 participants completed the survey. After reviewing the completed surveys, 
7 were excluded based on eligibility criteria. If participants did not reside in Illinois or 
Missouri, and/or was not an adult patient with PKU (i.e. a parent of a child with PKU), 
the survey response was excluded. A total of 1 7  surveys were left for review in this study. 
A small sample was anticipated for this study due to the population of adults with PKU. 
However, the reason for this unanticipated sample size was due to participation. The 
point person from the University of Illinois at Chicago Medical Center reported most 
adult patients from their clinic was involved in the PKU Organization of Illinois. Since 
IRB approval was not necessary from this organization, the point person explained it 
would be easier to send out the survey through this organization rather than wait for their 
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hospital's IRB approval process. Other reasons for lack of participation from point 
persons included the inability to obtain IRB approval from their hospital, no response to 
the email invitation, and new procedures being established for contacting patients about 
research. 
After reviewing number of responses from both Missouri and Illinois, only 1 
response survey was completed from Missouri. The shortage of Missouri responses 
resulted in a change of design for the study. Given the ratio of responses from Missouri 
and Illinois, a state comparison of financial barriers and responsibilities of adult patients 
with PKU was unattainable. The single Missouri response was excluded from the study 
and responses only from surveys in Illinois were used to answer the research questions 
that guided this study. The final number of survey responses included in this study was 
1 6. 
Research Questions Analysis 
Research Question 1:  What are the financial responsibilities associated with 
managing the treatment of an adult PKU patient in regard to purchasing medical 
foods? In each survey item medical food was categorized into medical formula, 
alternative medical protein products, and modified low-protein foods. Survey item 3 
identified how medical foods were paid for. Figure 1 shows all reported payment sources 
for each medical food. Individuals responded with multiple payment sources depending 
on the product being purchased. A state insurance program/Medicaid was most often 
reported as the payment method for medical formula (44%), whereas private insurance 
rarely contributed to coverage of medical formula ( 6% ). Fifty percent of responses 
consisted of "Does not apply", "I don't know", and "Other" for medical formula. Little 
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coverage was provided for alternative medical protein products and modified low-protein 












Medical Formula Alternative Modified Low-
Medical Protein Protein Foods 
Products 
• State Insurance Program I Medicaid • Private Insurance 
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Figure 1. Payment Sources of Medical Foods. This figure illustrates the percentage of 
reported payment sources used for obtaining medical foods. 
Survey item 4 asked individuals to identify how much they pay out-of-pocket per 
month for medical foods, which is illustrated in Figure 2. Eighty-one percent of 
individuals spent $0 on medical formula and the remaining 19% responded as "Does not 
apply" or "I don't know''. Eighty-one percent of adults paying $0 on medical formula 
was expected given the Illinois state mandates. Individuals purchasing alternative 
medical protein products (38%) and modified low-protein foods (50%) reportedly spend 
. 
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greater than $1 00, but less than $500 per month on medical food. This result was 
expected since state mandates only require coverage of medical formula (NORD, 2015). 
Additionally, there was· consistency in reports from another study identifying 60% of 
families with children of inherited metabolic disorders paid out-of-pocket for access to 
access to modified low-protein foods (Berry et al., 201 3b). While this study was 
conducted on a national level, assessing coverage from most states, it is still 
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Figure 2. Out-of-pocket Payment of Medical Foods. This figure illustrates the percentage 
of reported out-of-pocket expenses per month used for obtaining medical foods. 
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Survey item 5 was intended to describe the amount of coverage provided for 
medical foods, but this data was not analyzed due to the number of null responses. 
Research Question 2: To what extent does the state of residence, in regard to 
purchasing medical foods, influence the financial responsibilities associated with 
managing the treatment of an adult PKU patient? Due to a lack of participation from 
individuals living in Missouri, state of residence was not used to compare financial 
responsibilities associated with managing the treatment of an adult PKU patient. Instead, 
results from the state of Illinois were analyzed to describe the different financial 
components of managing the dietary treatment of PKU. Based on current state mandates, 
researchers hypothesized that adults living in Missouri would have less state and private 
insurance coverage, and would be required to pay for medical foods out-of-pocket or 
through other financial assistance programs (NORD, 2015). 
Research Question 3: To what extent does the purchase site of the medical 
foods influence the fmancial responsibilities associated with managing the treatment 
of an adult PKU patient? Figure 3 shows all reported purchase sites of medical foods. 
Individuals reported obtaining medical foods from a variety of sources. Some individuals 
had to use multiple purchase sites depending on the type of medical food being 
purchased. Of the 1 6  participants, 25 responses for purchase sites of modified low-protein 
foods were identified. Individuals mainly purchased modified low-protein foods from 
internet sources (44%). The remaining purchases took place from the manufacturer (16%) 
and/or a health food store (24%). Similarly, Berry et al., (2013b) identified 41 % of 
families purchasing modified low-protein foods from online stores, 16% from health food 
stores, and 14% from manufacturers. 
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Individuals who did not respond "Does not apply", "I don't know", or "Other", 
identified the state or county health department as their source of medical formula (69%), 
which is consistent with previous responses of participants reporting having state 
coverage and spending $0 for medical formula. Adults using alternative medical protein 
products reportedly used a variety of purchase sites including online stores (29%), the 
state or county health department (21 % ), pharmacy (7% ), manufacturer (7% ), and a 
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• State or County Health Department 
• Online Store 
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Modified Low- Protein 
Foods 
Figure 3. Purchase Site of Medical Foods. This figure illustrates the percentage of 
reported purchase sites used for obtaining various medical foods. 
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Research Question 4: To what extent do the financial responsibilities, in 
regard to purchasing medical foods, for the patient managing the treatment of PKU 
impact their dietary management? If so, how? A Likert-type scale was used to assess 
individuals' varying degrees of agreement or disagreement with statements presented 
regarding health care coverage and how access to medical foods may impact their dietary 
management. Figure 4 summarizes the responses in terms of agreement, neutral, and 
disagreement. Of the 1 6  participants, 10 agreed to purchasing medical food. Ninety-four 
percent of participants agreed that medical food is expensive and 44% reported that 
medical food is easy to purchase. A total of 84% of participants agreed that the cost of 
medical food and lack of health care coverage is a challenge to purchasing medical food, 
while 0% agreed to having adequate health care coverage of medical foods. 
This is an interesting perception given that most adults using medical formula 
receive coverage from the state and pay $0 out-of-pocket. Patients need access and 
coverage to modified low-protein products and alternative protein products, in addition to 
medical formula (Hafid & Christodoulou, 2015; MacDonald, 2000; MacLeod & Ney, 
2010). Providing coverage for only 1/3 of patient's treatment is not adequate. Lastly, 1 4  
participants agreed that compliance with dietary management would increase if there was 
better access to medical foods. Kemper, Brewer, & Singh (2010) conducted a qualitative 
study evaluating the attitudes and beliefs of women with PKU and a common theme 
discussed was about inadequate insurance coverage regarding dietary adherence. A 
majority of participants agreed that lack of insurance coverage and cost of medical foods 
is an issue impacting their dietary compliance. 
If cost of medical foods were not a factor, 
I would be more compliant with my diet. 
Medical food helps satisfy my appetite. 
Access to medical food improves 
compliance with my dietary . . .  
I feel like I have adequate health care 
coverage for medical food. 
The lack of health care coverage makes it 
challenging to purchase medical food. 
The cost of medical food makes it 
challenging to purchase medical food. 
The cost of medical food is expensive. 
It is easy to purchase medical food. 
I regularly purchase medical food. 
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Figure 4. Health Care Coverage of Medical Foods and Impact on Dietary Management. 
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Chapter 5 
Summary, Conclusions, and Implications 
Summary 
The purpose of this study was to identify the financial burdens associated with 
purchasing medical foods and the impact this has on the dietary management of adults 
with PKU. Research questions were written to identify the financial responsibilities of 
purchasing medical foods and whether the state of residence or purchase site influences 
the financial responsibilities. The fourth question examined if and how one's financial 
responsibilities impacted their management of dietary treatment. The study was a mixed­
method, non-experimental, survey design using an online questionnaire to collect data. 
Forty-five participants responded to the survey and only 24 participants completed the 
survey. The study had a lack of participation from patients living in Missouri, resulting in 
examining financial burdens from residents of Illinois only. Responses from participants 
living in Illinois that also met the inclusion criteria resulted in a sample size of 1 6  
participants. 
Data analysis showed that reported financial barriers associated with purchasing 
medical foods from adult patients living in Illinois aligned with the state mandated 
coverage (NORD, 201 5). There was no comparison of financial responsibilities from 
patients living in lllinois and Missouri, which would have been beneficial to illustrate 
differences in coverage and out-of-pocket expenses. Regardless of state coverage of 
certain medical foods from Illinois, the analysis also indicated that participants believe 
there is a lack of health care coverage for medical foods, the cost of medical food is 
expensive, and improved access could help with dietary compliance. Overall, these 
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results demonstrate that while adult patients living in Illinois have insurance coverage for 
certain medical foods, individuals still find inadequacies with health care coverage, 
which has effects on dietary compliance. Future studies need to compare insurance 
coverage an<l out-of-pocket expenses of medical foods for adults with PKU living in 
different states, as well as patients' perspective on compliance to dietary treatment 
associated with access to medical foods. 
Conclusions 
Results of this study showed the financial responsibilities associated with 
managing the treatment of an adult with PKU, however, result were inconclusive 
regarding a comparison of financial responsibilities depending on the state of residence. 
Research Question 1: What are the financial responsibilities associated with 
managing the treatment of an adult PKU patient in regard to purchasing 
medical foods? 
Most adult patients with PKU, living in the state of Illinois, who are using 
medical foods for treatment of PKU, use a state insurance program/Medicaid to pay for 
medical formula, resulting in a $0 per month out-of-pocket expenditure. On the contrary, 
adult patients receive no coverage or financial assistance, and pay out-of-pocket for 
modified low-protein foods and alternative medical protein products. On average, an 
adult patient will pay out-of-pocket greater than $ I 00, but less than $500 per month for 
modified low-protein foods and alternate medical protein products. The amount of 
coverage that is provided for medical foods is unknown due to number of null responses. 
Research Question 2: To what extent does the state of residence, in regard to 
purchasing medical foods, influence the financial responsibilities associated 
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with managing the treatment of an adult PKU patient? 
This research question was not able to produce results as only 1 participant 
completed the survey from Missouri a comparison of financial responsibilities between 
states was inconclusive. 
Research Question 3: To what extent does the purchase site of the medical 
foods influence the financial responsibilities associated with managing the 
treatment of an adult PKU patient? 
Most patients using medical formula receive their product from the state or county 
health department, which is expected since medical formula is covered through a state 
insurance program/Medicaid. However, the purchase site for alternative medical protein 
products and modified low-protein foods is variable. Of the adults using these products, 
online stores were most often used as a purchasing site. 
Research Question 4: To what extent do the financial responsibilities, in 
regard to purchasing medical foods, for the patient managing the treatment 
of PKU impact their dietary management? If so, how? 
More than half of the participants regularly purchase medical food and less than 
half find it easy to purchase medical food. Almost all patients agreed that the cost of 
medical food is expensive and that this makes it challenge to purchase medical food. 
Additionally, patients agreed that the lack of health care coverage for medical foods 
creates a barrier for purchasing medical food. Lastly, most patients agreed that access and 
cost of medical foods contributed to whether patients were compliant with their diet. 
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Limitations 
Several limitations were identified throughout this research study. The sample 
size consisted of 1 6  adults diagnosed with PKU. Although, this sample size was 
unavoidable given that the population of individuals diagnosed with PKU is about 20,000 
in the United States. This number significantly decreases when discussing only adult 
patients 18 years and older. Furthermore, not all adult patients are receiving care or 
treatment and that population is unknown, which leads into the second limitation of this 
study. 
Adults with PKU who were contacted to participate in this study were either 
patients of a clinic, being followed by a health care team, or were members of PKU 
community organizations. This creates a bias within the sample suggesting that only 
adults with PKU receiving treatment were recruited. Input from adults with PKU who are 
not receiving support, treatment, financial assistance or any other aid would have given 
more generalized responses for the PKU population. Inclusion of these individuals could 
have been achieved through online forums or social media networks such as Facebook. 
Another limitation was the design of the questionnaire survey. One question asked 
about participant's state of residence for the purpose of answering research question 2, 
but it also verified participants' residence for inclusion in the study. There was no 
question verifying the age of participants or the status of their diagnosis (i.e. "I have 
PKU" versus "I am a parent of a child with PKU"). Initially these questions were thought 
to be unnecessary given the invitation email and informed consent message stated the 
inclusion criteria for potential subjects to take the survey. However, after review of 
survey responses, two surveys had comments about personal experiences dealing with 
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inadequate health care coverage. Within the responses, each participant verified that he or 
she was a parent of a child with PKU. There is no way of knowing whether the 1 6  
participants i n  this study were all adults diagnosed with PKU. This would have made an 
even bigger difference if data were collected and analyzed from individuals living in 
Missouri because age limits are set on coverage mandates. 
In order to accommodate to the needs of point persons, the survey was opened at 
three different points. This was a limitation because individuals invited to take the survey 
had access to the survey at each point the survey was opened; the survey link stayed the 
same. This would have created a bias in length of time individuals had to complete the 
survey. Additionally, the different time frames the survey was opened was a limitation. 
The first survey opening was in December during the holidays and this could have 
generated a low response rate, whereas opening the survey in February may have been a 
time when people were checking their email more frequently. There was not an equal 
chance for participation response indicating this study could have resulted in more or less 
participants than the actual sample size. 
A final limitation in this study is personal bias. The researcher is an adult PKU 
patient who has been struggling with access, coverage, and cost of medical foods 
personally her whole life. To counter this bias, the researcher remained as objective as 
possible while conducting this study. 
Implications and Recommendations 
The results of this study did not fully answer the guided research questions 
regarding differentiating financial responsibilities between states. However, this is 
important in order to understand the variability of health care coverage, cost of medical 
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foods, and of out-of-pocket expenses adults with PKU are responsible for with the 
management of their dietary treatment. Reaching out to hospitals, clinics, and other PKU 
organizations is a great way to recruit participation, but utilizing other PKU forums and 
informal Facebook groups would be recommended for future studies in order to obtain a 
more generalized sample of the population. 
More research is continually emerging regarding cost of medical foods, insurance 
coverage and state policies, but it is important to investigate the impact this has on the 
individual. Compliance with dietary management is often low in adults with PKU, and it 
is important to determine if financial responsibilities have any effect on compliance. This 
study showed positive results from patients agreeing that there is a lack of health care 
coverage for medical foods and compliance would improve if cost was not an issue. This 
needs to be investigated further to determine how coverage or financial assistance could 
help with dietary compliance. Furthermore, studies demonstrating how patients' dietary 
management and compliance are affected are essential to show that there is a need for 
treatment coverage across the country for all ages. 
In a study conducted by Berry et al. (2013b), authors pointed out the importance 
of researching the financial barriers to access of medical foods for adults with PKU and 
other inherited disorders. This study aimed to investigate that need. However, further 
research is needed to continue investigating adult patient barriers to medical foods across 
the country. 
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Appendix A 
Insurance Coverage for Medical Foods Questionnaire Survey 
Please read each statement carefully and answer the questions to the best of your ability. 
For some questions, more than one answer is appropriate. There are no correct or 
incorrect answers. The survey should take about 1 0 - 1 5  minutes to complete. 
Section A: Source of Medical Foods 
1 .  What is your state of residence? 
a. 
2. Where do you get your medical foods: medical formula, alternate medical protein 
products, and modified low-protein foods? Check all that apply. 
Medical Formula= medical food in the form of a liquid or powder that provides essential 
nutrients and amino acids free of phenylalanine (e.g. Glyactin BetterMilk, Glyactin 
RESTORE, Vitaflo Cooler 10, PhenylAde 60, Lophelx LQ, etc.). 
Alternate Medical Protein Products = medical food in the form of drink mixes, beverages, 
bars, capsules, tablets, and gels that provide small amounts of phenylalanine or 
phenylalanine-free protein along with other essential nutrients and/or amino acids (e.g. 
Glyactin COMPLETE bars, Phlexy-1 0  Tablets, PhenylAde PheBLOC, etc.). 
Adult PKU Dietary Management 51 
Modified Low-Protein Foods = medical food products in the form of baking mixes, 
pastas, rice, and premade items that are designed to be similar to their normal 
counterparts, but supply very low amounts of phenylalanine. 
Alternate Medical Modified Low-
Medical Formula 
Protein Products Protein Foods 
Pharmacy J J 
State or county health 
CJ J 
department 
Internet source :J J 
Manufacturer (for example, 
:J J 
Mead Johnson) 
Home health care company 0 :J 
Health food store D J 
Hospital/clinic :J CJ 
I do not know 0 D 
Other: CJ J 
Section 8: Payment of Medical Foods 
3. How are your medical foods: medical formula, alternate medical protein 














Formula Protein Foods 
Products 
State insurance program I Medicaid/MA J J :J 
State insurance program health 
Maintenance organization I Medicaid HMO [] 0 :J 
/MA HMO 
Private insurance (ex. CBS and AETNA) that 
D 0 D 
was NOT paid for by your state 
Private health maintenance organization 
/HMO (for example: BlueCross Blue Shield, 
'.] 0 D 
Kaiser Permanente) that was NOT paid for by 
your state 
Medi gap :J 0 ;J 
MilitaryNeterans program (ex. TriCare, 
D D 0 
CHAMPUS, or CHAMP-VA) 
Indian Health Service =i J 0 
WIC J :J J 
Out-of-pocket J � J 
I do not have health care coverage '.] J :J 
Does not apply :::J J :J 
l do not know :J J '.J 
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[ Other: ____ _ J 
4. How much do YOU pay per MONTH for medical foods including: medical 
formula, alternate medical protein products, and modified low-protein foods? 
Include out-of-pocket payments and insurance co-payments. DO NOT include 
health insurance premiums or costs that are covered by insurance or another 
source. 
Medical Alternate Medical Modified Low-
Formula Protein Products Protein Foods 
$0 per month J J J 
More than $0 but less than $ 1 00 per 
J J =i 
month 
More than $ I  00 but less than $500 per 
J :J J 
month 
Between $500 and $1 000 per month J :J J 
More than $1 000 per month J J J 
Does not apply J :J J 
I don't know J :::J :::J 
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5. How much does your INSURANCE COMPANY pay per MONTH for medical 
foods including: medical formula, alternate medical protein products, and 
modified low-protein foods? 
Medical Alternate Protein Modified Low-
Formula Medical Products Protein Foods 
All of the cost 
(write the average amount per month :J $ D $ [] $ 
that your insurance covers) 
Some of the cost 
(write the average amount per month D $ ;:] $ J $ 
that your insurance covers) 
None of the cost J J 
I do not know J J 
Section C: Health Care Coverage of Medical Foods and Dietary Management 




Strongly Disagree Neutral Agree Strongly 
Disagree Agree 
a.) I regularly purchase medical food. 
b.) It is easy to purchase medical food. 
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c.) The cost of medical food is 
expensive. 
d.) The cost of medical food makes it 
challenging to purchase medical 
food. 
e.) The lack of health care coverage 
makes it challenging to purchase 
medical food. 
f.) I feel like I have adequate health 
care coverage for medical food. 
g.) Access to medical food improves 
compliance with my dietary 
management of PKU. 
h.) Medical food helps satisfy my 
appetite. 
i.) If cost of medical foods were not a 
factor, I would be more compliant 
with my diet. 
This section is for any comments you may have about this survey or your experiences 
with health insurance paying for medical foods including: medical formula, alternate 
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medical protein products, and/or modified low-protein foods. Any comments you wish to 
share are welcome. 
